| Date | Form | Description | Docs | XBRL | Pages |
| 08/17/18 | DEF 14A | Definitive proxy statements |
|
51 | |
| 07/27/18 | 8-K | Current report filing |
|
3 | |
| 07/27/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/11/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 05/14/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/14/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/14/18 | 8-K | Current report filing |
|
3 | |
| 04/11/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/11/18 | 4/A | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/11/18 | 144 | Filing for proposed sale of securities under Rule 144 |
|
2 |
Latest News & Events
Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays
Read More...Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
Read More...Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek™ Liquid Biopsy Technology
Read More...